A prospective randomised controlled trial to determine the early and late reactions after the use of iopamidol 340 (Niopam™) and iomeprol 350 (Iomeron®) in cardiac catheterisation

European Journal of Radiology

Volumn 61, Issue 2, 2007, Pages 342-350

  Vijayalakshmi, Kunadian ^a   Kunadian, Babu ^a   Wright, Robert A ^a   Hall, James A ^a   Stewart, Michael J ^a   Davies, Adrian ^a   Sutton, Andrew ^a   de Belder, Mark A ^a  

^a JAMES COOK UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

Adverse effects; Clinical study; Contrast media; Heart catheterisation; Iomeprol; Iopamidol; Prospective studies

Indexed keywords

CONTRAST MEDIA; MEDICAL APPLICATIONS; MONOMERS; PATIENT TREATMENT;

ADVERSE EFFECTS; CLINICAL STUDY; HEART CATHETERISATION; IOMEPROL; IOPAMIDOL; PROSPECTIVE STUDIES;

ELECTROCARDIOGRAPHY;

ADRENALIN; ANTIHISTAMINIC AGENT; ATROPINE; IOBITRIDOL; IODIXANOL; IOHEXOL; IOMEPROL; IOPAMIDOL; IOPENTOL; MEGLUMINE IOXAGLATE PLUS SODIUM IOXAGLATE; STEROID;

ADULT; AGED; AORTOGRAPHY; ARTICLE; BLOOD PRESSURE; BOLUS INJECTION; BRADYCARDIA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; ELECTROCARDIOGRAM; FACE EDEMA; FEMALE; FLUSHING; HEART ARREST; HEART ATRIUM FIBRILLATION; HEART BUNDLE BRANCH BLOCK; HEART CATHETERIZATION; HEART PALPITATION; HEART RATE; HEART VENTRICLE BIGEMINY; HEART VENTRICLE FIBRILLATION; HEART VENTRICLE TACHYCARDIA; HEART VENTRICULOGRAPHY; HEAT SENSATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; RASH; RIGOR; SIDE EFFECT; ST SEGMENT ELEVATION; SUPRAVENTRICULAR TACHYCARDIA; THORAX PAIN; TONGUE EDEMA; VOMITING; WHEEZING;

ADULT; AGED; AGED, 80 AND OVER; BRADYCARDIA; CONTRAST MEDIA; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HEAT; HUMANS; INJECTIONS, INTRAVENOUS; IOPAMIDOL; MALE; MIDDLE AGED; NAUSEA; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 33846264123     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2006.09.013     Document Type: Article

References (30)

1. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
2. Palmer F. The RACR survey of intravenous contrast media reactions. Final report. Australas Radiol 31 (1988) 621-628
3. Sutton A., Finn P., Grech E., et al. Early and late reactions after the use of iopamidol 340, ioxaglate 320, and iodixanol 320 in cardiac catheterisation. Am Heart J 141 4 (2001) 677-683
4. Sutton A., Finn P., Campbell P., et al. Early and late reactions following the use of iopamidol 340, iomeprol 350 and iodixanol 320 in cardiac catheterisation. J Invasive Cardiol 15 3 (2003) 133-138
5. Vijayalakshmi K., Williams D., Wright R., et al. A prospective randomised trial to determine the early and late reactions after the use of iopamidol 340 (Niopam) and iobitridol 350 (Xenetix) in cardiac catheterisation. J Invasive Cardiol 16 (2004) 707-711
6. Gallotti A., Uggeri F., Favilla A., Cabrini M., and de H.C. The chemistry of iomeprol and physico-chemical properties of its aqueous solutions and pharmaceutical formulations. Eur J Radiol 18 Suppl 1 (1994) S1-S12
7. Iomeprol-a promising new nonionic contrast medium. Drugs Therapeut Perspect 17 12 (2001) 1-4
8. Altman D. Practical statistics for medical research. 1st ed. (1991), Chapman & Hall, London
9. Rodriguez R.M., Gueant J.L., Imone-Gastin I., et al. The increased histamine release in ischaemic heart disease patients undergoing coronaroangiography is not mediated by specific IgE. Allergy 57 Suppl 72 (2002) 61-66
10. Walker A.C., and Carr D.H. Reactions to radiographic contrast media: an attempt to detect specific anti-contrast medium antibodies in the sera of reactor patients. Br J Radiol 59 702 (1986) 531-536
11. Katayama H., Yamaguchi K., Kozuka T., Takashima T., Seez P., and Matsuura K. Adverse reactions to ionic and nonionic contrast media. A report from the Japanese Committee on the Safety of Contrast Media. Radiology 175 (1990) 621-628
12. Greenberger P.A., and Patterson R. The prevention of immediate generalized reactions to radiocontrast media in high-risk patients. J Allergy Clin Immunol 87 (1991) 867-872
13. Mitsumori M., Hayakawa K., Soga T., et al. Effects of contrast media on the RR and QT interval during coronary arteriography. Acta Radiol 32 2 (1991) 120-123
14. Petersen R., McKay C.R., Kawanishi D.T., Kotlewski A., Parise K., and Niland J.C. Double-blind comparison of the clinical, hemodynamic, and electrocardiographic effects of sodium meglumine ioxaglate or iohexol during diagnostic cardiac catheterization. Angiology 43 9 (1992) 765-780
15. Goernig M., Kirmeier T., Krack A., Hartog C.S., Figulla H.R., and Leder U. Iohexol contrast medium induces QT prolongation in amiodarone patients. Br J Clin Pharmacol 58 1 (2004) 96-98
16. Armstrong S.J., Murphy K.P., Wilde P., and Hartnell G.G. Ventricular fibrillation in coronary angiography: what is the role of contrast medium?. Eur Heart J 10 10 (1989) 892-895
17. Katayama H., Spinazzi A., Fouillet X., Kirchin M., Taroni P., and Davies A. Iomeprol: current and future profile of a radiocontrast agent. Invest Radiol 36 2 (2001) 87-96
18. Fattori R., Piva R., and Schicchi F. Iomeprol and iopamidol in cardiac angiography: a randomised, double blind, parallel-group comparison. Eur J Radiol 18 Suppl 1 (1994) S61-S66
19. Beltramello A., Piovan E., and Rosta L. Double-blind comparison of safety and efficacy of iomeprol and iopamidol in carotid digital subtraction angiography. Eur J Radiol 18 (1994) S67-S72
20. Simonetti G., Guazzaroni M., and Carpanese L. A double blind comparative study of the safety and efficacy of iomeprol in renal intra-arterial digital subtraction angiography. Eur J Radiol 18 (1994) S73-S76
21. Ugolotti U., Larini P., and Marcato C. Peripheral arteriography with a new nonionic agent: comparison of iomeprol with iopamidol. Eur J Radiol 18 (1994) S77-S82
22. Valentini A., Tartaglione T., and Monti L. Iomeprol versus iopamidol in contrast enhanced computed tomography of thoracic and abdominal organs. Eur J Radiol 18 (1994) S88-S92
23. Simmons M., Waite D., and Galland R. Double-blind comparison of iomeprol-350 and iopamidol-340 in intravenous digital subtraction angiography for peripheral vascular disease. Clin Radiol 45 (1992) 338-339
24. Mathias K., Kempkes U., and Schmiedel E. Semiquantitative detection of pain and heat sensations in evaluation of contrast media in pelvic/leg angiography. Intraindividual double-blind study with iomeprol 350 and iopentol 350. Radiologe 36 2 (1996) 164-168
25. Schrader R., Esch I., Ensslen R., et al. A randomised trial comparing the impact of a nonionic (Iomeprol) versus an ionic (Ioxaglate) low osmolar contrast medium on post-PTCA ischemic complications. Circulation 96 8S (1997) 23I
26. Petersein J., Peters C., Wolf M., and Hamm B. Results of safety and efficacy of iobitridol in more than 61,000 patients. Eur Radiol 13 (2003) 2006-2011
27. Manske C., Sprafka J., and Wang J. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 89 (2000) 615-620
28. Parfrey P., Griffiths S., and Barret B. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both: a prospective controlled study. N Engl J Med 320 (1989) 143-149
29. Davidson C., Hlatky M., and Morris K. Cardiovascular and renal toxicity of a nonionic radiographic contrast agent after cardiac catheterisation: a prospective trial. Ann Intern Med 110 (1989) 119-124
30. Goernig M., Kirmeier T., Krack A., Hartog C.S., Figulla H.R., and Leder U. Iohexol contrast medium induces QT prolongation in amiodarone patients. Br J Clin Pharmacol 58 1 (2004) 96-98